CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
Authors
Nicole Caito
Ganesh B Chand
+13 more
Anna Eramo
Vincent T Grattan
Gerhard Gründer
Mark S Hixon
Hiroto Kuwabara
Erin Lessie
Ginger Nicol
Zachary Prensky
Thomas H Schindler
Lucy Tian
Andrew R Vaino
Ines Valenta
Dean F Wong
Publication date
1 December 2024
Publisher
Digital Commons@Becker
Doi
Cite
Abstract
Regulation of dopamine activity has important clinical consequences, most notably in schizophrenia. LB-102, N-methyl amisulpride, is a novel dopamine
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Digital Commons@Becker
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:digitalcommons.wustl.edu:o...
Last time updated on 26/02/2025
